Markets SixWeek Rally Highlights Divergent Stock Performance in Portfolio
Japan China Trade Chiefs Hold First Bilateral Talks Since Escalating Trade Dispute
UK Bank Holiday Travel Hottest Day of Year May Boost Tourism but Disrupts Commute
LNG Tankers and Oil Cargo Transit Strait of Hormuz Signaling Potential Easing of Regional Tensions
REPLOID Group AG Faces Auditor Appointment Issues 2025 Annual Report Delayed
Trump Postpones AI Executive Order Signing Cites Concerns Over Potential Regulatory Blocker
Mustang Bio Inc MBIO Q4 2024 Earnings Massive EPS Miss Amidst No Revenue
DDOG Q1 2026 Earnings EPS Surprise of 1585 Fuels Modest Gains
Castle Biosciences Q1 2026 Earnings Narrowly Beats EPS Estimates but Stock Declines
RWAYI Q1 2026 Earnings EPS Misses Estimates as Portfolio Adjustments Pressure Results
PKST Q1 2026 Earnings Significant EPS Miss Amid Challenging Real Estate Market
BBNX Q1 2026 Earnings Narrow Beat on EPS Amid Limited Revenue Disclosure
AZZ Inc Nudges Higher Maintains Position Above Key Support
AMCON Distributing DIT Holds Steady at 8088 Neutral Ground or Pause Before a Move
EverQuote EVER Edges Higher Consolidating Near Key Resistance Amid Sector Movements
STRD Preferred Stock Holds Steady Near 7350 as Support and Resistance Levels Come into Focus
Optex Systems Holdings OPXS Posts Modest Gains Amid Tight Trading Range
Tyra Biosciences TYRA Q1 2026 Earnings Net Loss Slightly Wider Than Street Estimates
PLMR Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Not Disclosed
TBH Q4 2025 Earnings Massive EPS Miss Overshadowed by Stock Surge
Wendys Q1 2026 Earnings EPS Beats Estimates by 241 as Stock Gains
Annexon Inc ANNX Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline but No Revenue Yet
Tenax Therapeutics Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Pipeline Progress
Satellites and AI Deployed to Track UK Hedgehog Decline Highlighting Environmental Monitoring Opportunities
51Talk COE Q3 2025 Earnings Wider Loss Weighs on Shares as Revenue Details Remain Unclear
Treace Medical Concepts TMCI Declines 211 as Stock Nears Key Support at 264